Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Arpine Khudanyan, BS, Sven Reid Olson, MD, Thomas G. Deloughery, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 2449.

https://doi.org/10.1182/blood-2019-129653

Published: 2019

Journal Articles

NTBI Is Transiently Generated from Two Compartments during a Single Dose of Intravenous Iron - a Randomized Controlled Clinical Study

Maciej W Garbowski, MD PhD, Sukhvinder S Bansal, PhD, John B. Porter, MA MDFRCP FRCPath, Susanna Burckhardt, PhD, Robert Hider, PhD

Blood (2019) 134 (Supplement_1): 2234.

https://doi.org/10.1182/blood-2019-125618

Published: 2019

Journal Articles

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Ralph V. Boccia, MD, Naomi V Dahl, PharmD, William E Strauss, MD

Blood (2019) 134 (Supplement_1): 2236.

https://doi.org/10.1182/blood-2019-126149

Published: 2019

Journal Articles

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Susan Kirk, PA-C, Donald Mahoney, MD, Melanie Brooke Bernhardt, PharmD, Jacquelyn M. Powers, MD,MSc

Blood (2019) 134 (Supplement_1): 2240.

https://doi.org/10.1182/blood-2019-129159

Published: 2019

Journal Articles

Multidisciplinary Implementation of an Iron Deficiency Anemia in Pregnancy Treatment Protocol

Pooja Mehra, MD, Surabhi Palkimas, PharmD, Laura Parsons, MD, Theresa Libby, RN, BSN, Leslie Ward, PharmD, Christian Chisholm, MD, Kelly Mercer Davidson, MD

Blood (2019) 134 (Supplement_1): 2121.

https://doi.org/10.1182/blood-2019-123902

Published: 2019

Journal Articles

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Michael Boxer, MD

Blood (2019) 134 (Supplement_1): 962.

https://doi.org/10.1182/blood-2019-122154

Published: 2019

Journal Articles

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Chris LaVallee, M.S, Patrick Cronin, M.A, Isha Bansal, M.S, Jackie Kwong, PhD PharmD, Ralph Boccia, MD

Blood (2019) 134 (Supplement_1): 3445.

https://doi.org/10.1182/blood-2019-125793

Published: 2019

Journal Articles

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Jeffrey A. Gilreath, PharmD, Tamta Makharadze, MD, Ralph V. Boccia, MD, Anna Krupa, PharmD, David H. Henry, MD

Blood (2019) 134 (Supplement_1): 3535.

https://doi.org/10.1182/blood-2019-132135

Published: 2019

Journal Articles

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Caleb J Scheckel, DO, Didar Yanardag Acik, MD, Aneel A. Ashrani, MD MS, C. Christopher Hook, MD, Lindsey Ann Kluck, APRN, CNP, MSN, Ariela L. Marshall, MD, Rajiv K. Pruthi, MBBS, Aishwarya Ravindran, MBBS, Mithun Vinod Shah, MD PhD, Alexandra Wolanskyj, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 4815.

https://doi.org/10.1182/blood-2019-127306

Published: 2019

Journal Articles

Hypophosphatemia after High Dosage Iron Substitution with Ferric Carboxymaltose (FCM) and Iron Isomaltoside (IM) — the Randomised Controlled Home Afers 1 Trial

Insa E. Emrich, MD, Fabio Lizzi, Seiler-Mußler Sarah, MD, Christian Ukena, MD, Dominic Kaddu-Mulindwa, MD, Michael Böhm, MD, Stephan Stilgenbauer, Danilo Fliser, MD, Vincent Brandenburg, Gunnar Heine, MD

Blood (2018) 132 (Supplement 1): 3627.

https://doi.org/10.1182/blood-2018-99-114386

Published: 2018

Journal Articles

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Michael Auerbach, MD, William E Strauss, MD, Iain C. Macdougall, MD, Kristine Bernard, MPH, Robert F Kaper, MD, Glenn M Chertow, MD MPH, Zhu Li, PhD, Anton Trochanov, MD, Naomi V Dahl, PharmD, Julie Krop, MD

Blood (2017) 130 (Supplement 1): 3500.

https://doi.org/10.1182/blood.V130.Suppl_1.3500.3500

Published: 2017

Journal Articles

Intravenous Iron Supplementation Alone for Treatment of Anemia in Cancer Patients

Silvia Park, Chul W. Jung, MD PhD, Jun Ho Jang, MD PhD

Blood (2017) 130 (Supplement 1): 4756.

https://doi.org/10.1182/blood.V130.Suppl_1.4756.4756

Published: 2017

Journal Articles

Iron Supplementation: What's New?

Iain C. Macdougall, MD

Blood (2017) 130 (Supplement 1): SCI-43.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-43.SCI-43

Published: 2017

Journal Articles

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Chunlin Qian, PhD, Winghan Jacqueline Kwong, PhD PharmD

Blood (2017) 130 (Supplement 1): 2087.

https://doi.org/10.1182/blood.V130.Suppl_1.2087.2087

Published: 2017

Journal Articles

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy

Jacquelyn M. Powers, MD, Mark P. Shamoun, MD, Timothy L. McCavit, MD, Leah Adix, CCRP, George R. Buchanan, MD

Blood (2015) 126 (23): 4552.

https://doi.org/10.1182/blood.V126.23.4552.4552

Published: 2015

Journal Articles

Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Athina Drakou, MD, Christos Poziopoulos, MD, Alexandra Margeli, PhD, Ioannis Papassotiriou, PhD, Demetrios Vlahakos, MD

Blood (2015) 126 (23): 949.

https://doi.org/10.1182/blood.V126.23.949.949

Published: 2015

Journal Articles

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Eleonora Arboscello, MD, Elisa Molinari, MD, Francesco Tolomeo, MD, Lisette Del Corso, MD, Luana Vignolo, MD, Gianluca Ubezio, MD, Paolo Carlier, MD, Paolo Strada, MD, Riccardo Ghio, PhD, Francesco Puppo, PhD, Paola Mangini, MD, Sabrina Beltramini, MD, Pietro Dulbecco, MD, Paola Anserini, MD, Maria Teresa van Lint, MD, Andrea Bacigalupo, MD, Fabio Guolo, MD, Marino Clavio, MD, Andrea Bellodi, MD

Blood (2015) 126 (23): 5583.

https://doi.org/10.1182/blood.V126.23.5583.5583

Published: 2015

Journal Articles

Anemia during the Pregnancy: The Management and Outcomes Depending on the Etiology

Maria A. Vinogradova, MD, Tatiana A. Fedorova, MD PhD, Elena V. Strelnikova, MD, Oleg Rogachevsky, MD PhD, Roman G. Shmakov, MD PhD, Eugenia S. Polushkina, MD

Blood (2014) 124 (21): 4830.

https://doi.org/10.1182/blood.V124.21.4830.4830

Published: 2014

Journal Articles

Evaluation of Serum Oxidative Stress Indices Following Intravenous Iron Delivery in Women with Iron Deficiency Anemia

James Connor, PhD, Angelia Butcher, BS

Blood (2014) 124 (21): 2683.

https://doi.org/10.1182/blood.V124.21.2683.2683

Published: 2014

Journal Articles

Clinical Criteria for Transitioning from Oral to IV Iron Replacement Therapy in Patients with Iron Deficiency Anemia

Maureen Okam, MD, Todd Koch, Minh Ha Tran, DO

Blood (2014) 124 (21): 211.

https://doi.org/10.1182/blood.V124.21.211.211

Published: 2014

NARROW

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

NTBI Is Transiently Generated from Two Compartments during a Single Dose of Intravenous Iron - a Randomized Controlled Clinical Study

Severe Hypophosphatemia in Patients with Cancer Following IV Iron Treatment: Results from a Large Comparative Trial

Phosphorus Levels in Iron Deficient Children Treated with Ferric Carboxymaltose

Multidisciplinary Implementation of an Iron Deficiency Anemia in Pregnancy Treatment Protocol

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Impact of Parenteral Iron Therapy on Hemoglobin Normalization: A Retrospective Analysis

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Hypophosphatemia after High Dosage Iron Substitution with Ferric Carboxymaltose (FCM) and Iron Isomaltoside (IM) — the Randomised Controlled Home Afers 1 Trial

Randomized, Double-Blind Trial of Ferumoxytol Compared to Ferric Carboxymaltose for Treatment of Iron Deficiency Anemia: Safety and Efficacy

Intravenous Iron Supplementation Alone for Treatment of Anemia in Cancer Patients

Iron Supplementation: What's New?

Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Unresponsive to Oral Iron Therapy

Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Ambulatory Management of Anemia: A Retrospective View from an Italian Multidisciplinary Team

Anemia during the Pregnancy: The Management and Outcomes Depending on the Etiology

Evaluation of Serum Oxidative Stress Indices Following Intravenous Iron Delivery in Women with Iron Deficiency Anemia

Clinical Criteria for Transitioning from Oral to IV Iron Replacement Therapy in Patients with Iron Deficiency Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only